Markets have been anticipating hard data ‘catching down’ to soft data for some time but the 90-day pause in the imposition of ...

In-N-Out’s playbook has always held an air of mystery. Partly because the brand keeps operating principles close to the vest, ...

The payments software company may get a boost if the U.S. budget allows for more consumer health savings accounts. It could use a lift, given recent shareholder dismay.

NewAmsterdam shared new Phase 3 data showing obicetrapib reduced LDL-C by 33% and impacted Alzheimer's biomarkers ahead of ...

The FDA rejected Axsome's AXS-14 fibromyalgia, prompting a new trial and pushing the expected drug launch to 2028.

A "sub-study" of a late-stage clinical trial found the drug, obicetrapib, significantly reduced levels of a certain type of ...

Property & casualty insurer, reinsurer, and brokerage stocks slipped in Monday trading after management commentary from Ryan ...

Empaveli reduced proteinuria by 68% versus placebo in glomerulopathy and glomerulonephritis, an effect that was sustained ...

Oklo’s approach to fuel fabrication and recycling makes it an attractive investment, says Seaport Research Partners.

Cameco supplies uranium to major utilities but also has exposure to new nuclear technology and standard nuclear reactors.

Austin Blair Johnson was sentenced in 2018 to 15 years in prison for shaking his infant son and causing severe brain injuries ...

Under the stewardship of the MyMichigan Health Foundation, $194,500 has been awarded to 99 students for the 2025-2026 school year from The Bernard F. and Melissa Anne Bailey Family Fund.